(1)
Hird, A. E.; Magee, D. E.; Cheung, D. C.; Matta, R.; Kulkarni, G. S.; Nam, R. K. Abiraterone Vs. Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer: A Microsimulation Model. CUAJ 2020, 14, E418-27.